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Objective: Differences concerning alteration of hemostatic, hemolysis, and hematologic 
parameters after transfusion of blood from a cell-separation (CS) device or whole blood 
autotransfusion (WBA) were prospectively evaluated during major aortic surgery. 
Method: Thirty-two patients were randomly selected to receive autologous retransfusion by 
using either WBA or a CS device. Coagulation and hematologic parameters and levels of 
hemolytic degradation products (HDP) were assessed in the retransfused blood and in the 
patients' plasma preoperatively and until 24 hours after autologous retransfusion, 
respectively. 
Results: Mean volume of retransfused blood was 1072 + 473 ml in the WBA group and 
556 -+ 504 in the CS group. Level ofHDP (bilirubin, free hemoglobin [free HB], and lactic 
dehydrogenase [LDH]) and hemostatic disturbances (d-dimer value, fibrin degradation 
products) were significantly higher in the WBA device compared with the CS blood. Blood 
samples taken from the WBA group revealed significantly higher levels of HDP (free HB, 
LDH) and of d-dimer values after autotransfusion compared with the CS group. 
Conclusion: Levels of HDP and the degree of hemostatic disturbances were significantly 
higher in retransfused whole blood compared with CS blood. Hemostatic disturbances and 
levels of HDP were significantly pronounced in the patients' plasma fter WBA compared 
with CS. CS retransfused blood seems to be of superior quality compared with WBA and 
the degree of hemolysis and hemostatic disturbances i  minor after CS retransfusion. 
(J Vasc Surg 1996;24:102-8.) 
Salvage autotransfusion, first performed in 1818, 
entails the collection of blood shed during surgery 
and its immediate reinfusion. ~Transfusion-related 
transmission of infectious diseases has renewed the 
interest in methods that reduce the requirement of 
homologous transfusions? Autotransfusion is cur- 
rently performed by using two different echniques: 
unwashed whole blood autotransfusion (WBA) or 
cell-separated washed and concentrated blood au- 
totransfusion (CS). As cell savers remove plasma from 
salvaged shed blood, potentially toxic products of 
injured red cells and procoagulants are reduced in the 
retransfused blood. However, other essential blood 
elements, such as platelets, plasma proteins, and 
clotting factors, are eliminated. 3,4 WBA of shed blood 
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after anticoagulation returns platelets and plasma 
proteins, but unwanted activatcd coagulation factors 
and hemolytic degradation products are also retrans- 
fused, s Experimental animal studies comparing CS 
against WBA demonstrated minor hemostatic distur- 
bances and minor hemolysis in the group receiving CS 
blood. 6 Previous reports of severe coagulation distur- 
bances after WBA led to the use of citrate anticoagu- 
late and limited thc amount of autologous retransfu- 
sion up to 3000 mlfi '7'8 With these modifications, 
several groups could demonstrate the use of WBA 
without any adverse clinical complications. 9-1~ How- 
ever, more recently hcmostatic disturbances after 
WBA with lethal outcome have been reported. 12'13 
The extent of hemolysis and ofhemostatic distur- 
bances induced by WBA compared with CS and its 
clinical significance remains controversial. ~4In this 
study, vital organ function was studied in patients 
undergoing elective aortic reconstructive surgery by 
using either CS or WBA (Solcotrans Solco Basle AG, 
Birsfeld, Switzerland). Furthermore, alteration of 
various hemolysis, hematologic, and coagulation pa- 
rameters was analyzed in the retransfused blood and 
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in the patients' plasma preoperatively and until 24 
hours after autologous retransfusion, respectively. 
MATERIAL AND METHODS 
Patients. Thirty-two patients undergoing elective 
major aortic surgery were prospectively randomly 
selected to receive ither WBA or CS for intraopera- 
tire autotransfusion. Vital organ function, total blood 
loss, and transfusion and infusion requirements were 
recorded. The patients' demographic data are de- 
picted in Table I. 
Laboratory methods. For laboratory analysis, 
samples from the retransfused blood and blood 
samples from the patients were obtained preopera- 
tively and at 1 hour, 6 hours, and 24 hours after 
retransfusion of the autologous blood. Hematologic 
studies included cell count, hemoglobin, and he- 
matocrit (all automated cell counter). Hemolytic 
degradation products were determined by measuring 
haptoglobin (nephelometry), free plasma hemoglo- 
bin (photometry), lactic dehydrogenase (kinetic 
method), and direct and total bilirubin (colorim- 
etry). Coagulation parameters included estimation of 
fibrinogen, partial thromboplastin time, prothrom- 
bin time (all automated clotting assay), d-dimer 
screen, and fibrin degradation products (latex ag- 
glutination). A complete biochemical profile and 
serial arterial and venous blood gas analysis were 
obtained perioperatively. 
Autotransfusion protocol. Patients were sys- 
tematically administered heparin (2 mg/kg body 
weight). Protamine was used for reversal of heparin 
equally in both groups. The same suction tip was used 
in both groups. Retransfusion was performed in both 
groups with a 40 Bm blood filter. Autologous blood 
was retransfused until the patient was transferred to 
the surgical intensive care unit. Either preoperatively 
removed autologous blood or homologous blood was 
administered if the hemoglobin value dropped to 
<6.2 mmol/L postoperatively. 
Whole blood autotransfusion. A portable, plas- 
tic disposable autotransfusion device consisting of a 
500 ml capacity blood-compatible bag within a semi- 
rigid outer shell (Solcotrans, Solco Basle AG) was 
used for WBA. Shed blood was collected from the 
operative field by low suction pressure (75 to 100 mm 
Hg) to minimize red cell trauma. Salvage for WBA 
was performed only after systemic administration of 
heparin. Twenty-five ml 3.8% sodium citrate for 
additional anticoagulation was added to each con- 
tainer before heparinized blood entered the system. 
Cell separation. Shed blood was collected uring 
the entire procedure. Blood was retrieved from the 
operation field with a double lumen suction catheter 
and immediately anticoagulated with Ringer's 
lactate/heparin solution (25,000 units ofheparin per 
1000 ml Ringer's lactate). The cardiotomy reservoir 
included a 240-micron filter to remove larger debris. 
The filtered blood was pumped to a bowl centrifuge, 
centrifuged, and washed. The supernatant was dis- 
carded, and the erythrocyte concentrate was pumped 
to a retransfusing bag (Haemolite II, Haemonetics, 
Munich, Germany). 
Statistical methods. Statistical analysis of hema- 
tologic, coagulation, and hemolytic degradation pa- 
rameters was performed by using multiple analysis of 
variance (group and time) with orthogonal contrast. 
Intragroup comparisons were performed as differ- 
ences from measure points after retransfusion com- 
pared with the preoperative value. Comparison of 
parameters in the retransfused blood and comparison 
of surgical, demographic, and infusion/transfusion 
requirements between the groups was performed by 
using the Mann-Whitney U test. A p value <0.05 
(two-tailed) was considered significant. Analyses were 
performed by SPSS/PC+. MI data were expressed as 
mean values + SD. 
RESULTS 
Sttrgical data, transfusion requirements, and 
patient outcome. Table I indicates that no differ- 
ences concerning surgical and demographic data, 
total intraoperative blood loss, amount of retrans- 
fused blood, intraoperative transfusions, and require- 
ment of either homologous or preoperative r moved 
autologous blood existed between the two groups 
(Mann-Whitney U test). Mean intraoperative auto- 
transfusion was 1072 + 473 ml in the WBA group and 
556 _+ 504 ml in the CS group (p = not significant). 
No deterioration concerning monitored vital organ 
function (renal, pulmonary, cardiac) was observed in 
the studied population (for serum creatinine see 
Fig. 1D; other data not shown). 
Comparison of samples from the retransfused 
blood. Significant differences of retransfused blood 
between the two systems concerning hemolysis, he- 
matologic, and coagulation parameters are depicted 
in Table II. Hemolysis was significantly pronounced 
in the WBA set. Because of plasma elimination, 
haptoglobin was reduced under the lower normal 
range in the CS blood in all cases. Hematocrit and 
hemoglobin values were significantly higher in the 
CS blood compared with WBA. Extraction of plate- 
lets resulted in a significantly higher amount of 
platelets in the WBA set. Concerning the coagu- 
lation parameters, a significantly higher amount of 
d-dimers and fibrin degradation products (FDP) was 
detected in the WBA compared with CS blood; no 
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Table I. Demographic and surgical data 
Whole blood autotransfusion Cell-separated blood 
Age (yrs) 65 ± 9 65 ± 9 
Weight (kg) 78 ± 13 72 ± 14 
Height (cm) 172 ± 8 172 ± 6 
Sex: female/male 3/13 2/14 
Underlying disease 
AAA 10 9 
Atherosclerosis 6 7 
Operative procedure 
Bifurcation prosthesis 13 12 
Straight tube 3 4 
Intraoperative homologous transfusion (ml) 494 ± 758 312 ± 479 
Transfusion of preoperative r moved autologous 219 ± 482 500 ± 463 
blood (ml) 
Intraoperative colloids (ml) 1219 ± 306 1438 ± 403 
Intraoperative crystalloids (ml) 3875 ± 1028 3586 ± 932 
Postoperative homologous blood transfusion (ml) 169 ± 298 250 ± 577 
Estimated intraoperative blood loss (ml) 781 ± 763 1031 ± 1154 
Differences between groups not significant (Mann-Whitney U test). 
AAA, Abdominal aortic aneurysm. 
Table II. Comparison of samples of retransfused blood 
Parameter Whole blood autotransfusion Cell-separated blood Normal range (SI units) 
Hemolysis 
Bilirubin, direct* 18.6 + 9.9 (1.7-44.5) 8.6 ± 10.3 (0 43) 0-7 gmol/l  
Bilirubin, total* 26.5 ± 9.9 (10.3-49.6) 10.9 ± 9.9 (1.7-44.5) 0-7 ~tmol/l 
Free hemoglobin'~ 200 ± 115 (23-389) 86 ± 74 (7-325) 0-6.2 mmol/l 
Haptoglobin* 1.0 ± 0.45 (0.51-2.1) <0.41 0.1-0.3 g/1 
Lactic dehydrogenase* 9.5 ± 3.83 (1.6-16.7) 4 ± 2.07 (1.6-10.6) 1.83-3.5 gkat/1 
Hematologic 
Erythrocyte count* 2.5 +- 0.42 (1.75 3.32) 4.7 ± 0.78 (3.16-5.53) 4.15-4.90 x 1012/1 
Hemoglobin* 5.03 ± 0.77 (3.6-6.5) 9.1 ± 1.7 (5.4-10.6) 7.9-11.2 mmol/1 
Hematocrit* 0.23 ± 0.04 (0.16-0.32) 0.43 ± 0.08 (0.27-0.5) 0.37-0.52 
Platelet count* 84 ± 39 (26-164) 27 ± 39 (7-150) 150-350 × 109/1 
Coagulation 
FDP 166 ± 56 (62-260) 66 ± 28 (30-124) nmol/1 
D-dimer:~ 0.88 ± 0.24 (0.29->1.0) 0.76 ± 0.18 (0.41->I.0) <0.5 mg/l  
*p_< 0.001 
tP -< 0.01 
~:p < 0.05 
Values are mean ± SD (min - max); Mann-Whitney U test. 
further differences regarding the other coagulation 
parameters were detected. 
Intergroup comparison. Intergroup and intra- 
group comparisons are depicted in Fig. 1C. No 
differences concerning hematologic parameters could 
be detected between the two groups (Fig. 1A, B,C). 
The amount of HDP in the patients' plasma was 
higher in the WBA group. This finding is reflected in 
a significantly higher amount of free plasma hemo- 
globin and LDH 1 hour after autologous blood 
retransfusion (Fig. 2A, C). 
D-dimer levels were significantly higher in the 
WBA group 1 hour and 6 hours after retransfusion 
(Fig. 3A). No differences concerning the other mea- 
sured coagulation parameters could be detected be- 
tween the two groups (see Fig. 3B, C,D). 
Intragroup comparison. Except for a decrease in
platclet count after retransfusion i both groups, no 
further differences versus preoperative values were 
observed in the intragroup comparison concerning 
hematologic parameters ( ee Fig. 1 A,B,C). 
Total and direct bilirubin were elevated 1 and 6 
hours after retransfusion i both groups (Fig. 2D). 
LDH remained elevated after CS and WBA through- 
out the study period (Fig. 2C). Haptoglobin re- 
mained depressed throughout he study period in 
both groups (see Fig. 2B). 
No changes in FDP content were observed after 
WBA or after CS retransfusion (Fig. 3B). Prothrom- 
bin time was elevated at 1 hour after retransfusion i
both groups (Fig. 3D). Fibrinogen levels were de- 
pressed in both groups I hour after etransfusion, and 
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Fig. 1. Course of hematologic parameters and serum creatinine. A~ Erythrocyte count. B, 
Platelet count. C, Hemoglobin and hematocrit. D, Serum creatinine. M1 values are means; error 
bars signify standard deviation. Multiple analysis of variance with contrast. WBA and CS for time: 
*p < 0.05, **p < 0.01 (intragroup differences). 
a reactive hyperfibrinogenemia was observed in both 
the CS and the WBA group 24 hours after retransfu- 
sion (see Fig. 3C). 
D ISCUSSION 
Autotransfusion eliminates the risk of  transmis- 
sion of  infectious disease in contrast to homologous 
transfusion. However, until recently, clinically signifi- 
cant disturbances of  the hemostatic system and sig- 
nificant hemolysis remained an unresolved prob- 
lem. s'7,8,12,ls'16 In 1968 I(lebanoff and Watldns 7 de- 
scribcd a system for WBA that prompted its usc 
worldwide. In the same year Wilson and Taswell ~8 
developed the first CS device. Although both auto- 
transfusion systems are currently in clinical use, the 
magnitude ofhemostatic and hemolytic disturbances 
after WBA c6mpared with CS and possible clinical 
side effects of  WBA are controversially discussed. ~4 
Our results demonstrated a significantly higher 
amount of  platelets in the retransfused whole blood 
compared with CS blood. However, no differences 
concerning hematologic parameters occurred after 
retransfusion of  either WBA or CS blood in the 
studied population, despite a significant minor 
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Fig. 2. Course of hemolytic degradation products. A, Free hemoglobin. B, Haptoglobin. C, 
Lactic dehydrogenase. D, Total bilirubin. WBA and CS for time: *p< 0.05, **p< 0.01, 
***p < 0.001 (intragroup differences). Between WBA vs. CS: +p < 0.05, +++p < 0.001 (inter- 
group differences). 
amount ofplatelet retransfusion in the CS group. Our 
results may be due to the only moderate amount of 
retransfused blood; others demonstrated a drop in 
platelet count after retransfusion of a larger amount of 
either CS or WBA in both groups. 6'19 Our findings 
contrast with Kalra et al., 2° who observed a significant 
decrease in platelet count after retransfusion of com- 
parable amount of CS blood. In this study, platelet 
measurements were automatically performed, though 
there was no possibility to differentiate between single 
functioning platelets or platelet aggregates. Large 
amounts of microaggregates were detected in sal- 
vaged whole blood; therefore it might be speculated 
that the lack of differences in platelet count compared 
with retransfusion after CS may be due to significant 
formation of platelet microaggregates before re- 
transfusion. 349,21 However, the content of active 
platelets has not yet been examined when the salvaged 
whole blood had been passed through a filter sys- 
tem. Differences in hemoglobin level and in hemat- 
ocrit of salvaged blood bctwcen both salvaging sys- 
tems are explained by the hemoconcentration of the 
CS device. 
Hemolysis after retransfusion of WBA or CS 
blood has frequently been descr ibed.  6'12'16'21'22 In 
accordance with other reports, the incrcasc of free 
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hemoglobin and LDH levels was lower in the CS 
group than in the WBA group in this s tudy .  6'14'22 
Intergroup comparison showed that more HDP were 
retransfused by WBA than by CS. This finding is 
reflected by higher levels of free hemoglobin and 
LDH as well as by lower levels of haptoglobin in the 
WBA group (despite partial removal of this protein by 
the cell-separating process). 
Our results demonstrated pronounced hemostatic 
activation in the WBA set, indicated by significantly 
higher d-dimer and FDP levels in the WBA set 
compared with CS. D-dimer levels were significantly 
higher in the WBA group than in the CS group during 
the first 6 hours after retransfusion. This important 
result indicates accelerated fibrinolysis. D-dimer levels 
remained increased in both groups throughout the 
study period. These findings concur with experimen- 
tal studies examining coagulation disturbances and 
the degree of hemolysis by using either CS or WBA in 
baboons. 6 Corresponding to our results, no FDP 
increase has been observed in 10 patients receiving CS 
blood during aortic reconstruction) ° Significant in- 
creases of FDP levels had been reported in a larger 
patient collective receiving a total amount of 
1729 _+ 68 ml of WBA. 12 Long et al. ~4 observed a 
significant increase in D-dimer value and FDP levels 
JOURNAL OF VASCULAR SURGERY 
108 Barrels gt al. July 1996 
after retransfusion of a mean of 1552 + 741 ml WBA 
in 13 patients compared with 13 patients receiving CS 
blood. 
High levels of free hemoglobin generated by 
autotransfusion may be nephrotoxic. Reinfusion of 
hemolytic autologous red cell material is lmown to be 
capable of inducing intravascular coagulation in 
dogs. 23 The amount of reinfused hemolytic autolo- 
gous blood necessary to cause nephrotoxicity or 
coagulation disturbances is unknown. It is not clear if 
hemolytic nephrotoxicity is a dose-related process. 3
Despite numerous reports of safe application of WBA 
transfusion, severe coagulation disturbances have 
been described. 12,13 It might be speculated that the 
nephrotoxicity that was observed after transfusion of 
hemolytic blood may also be contributed by the 
activation of the coagulation system and increased 
fibrin generation. 24 
The findings of this study demonstrate a lower 
content of HDP and fewer coagulation disturbances 
after retransfusion of CS blood compared with WBA. 
Clinical deterioration of renal, pulmonary function, 
or hemorrhage from coagulation disturbances did not 
occur in any case. However, only a low volume of 
blood was retransfused in this study, and clinical or 
hematologic/hemostatic d sturbances may manifest 
only ifa larger amount of blood is retransfused. Ouriel 
et al.12 reported hemostatic disturbances leading to 
death in one patient in a larger patient group receiving 
WBA. Others reported impaired hemostasis after 
WBA of blood from thoracic cavities in patients un- 
dergoing cardiac surgery. 2s The combination of WBA 
and aprotinin in a patient undergoing myocardial re- 
vascularization resulted in severe coagulation distur- 
bances (high d-dimer levels) with a lethal outcome. Is
We therefore conclude that cell-separated blood 
seems to be of better quality regarding coagulation 
disturbances and level of hemolytic degradation prod- 
ucts. Larger studies are necessary to evaluate the 
significance of these findings regarding mortality and 
morbidity after retransfusion of cell-separated blood 
or whole blood autotransfusion. 
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